Study of Ganzhixiao capsules for MAFLD with damp heat
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests Ganzhixiao capsules for people with MAFLD (a type of fatty liver disease) who also have symptoms of 'damp heat' (like feeling heavy and sluggish). It aims to see if the capsules can help improve liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- Your body mass index (BMI) is 24 or higher
- You have been diagnosed with MAFLD (fatty liver) in the last 2 years by imaging or biopsy
- Your fatty liver is the 'damp heat' type
- You do not have other liver diseases, advanced liver scarring, or liver cancer
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called diacerein to see if it can help people with a type of fatty liver disease called MASLD. If you have fatty liver that is not caused by alcohol or other illnesses, this study may be a good fit for you.
This trial tests whether dihydroartemisinin, a malaria drug that may reduce liver fat, helps people with metabolic fatty liver disease. It is for adults aged 18 to 45 who have a fatty liver and at least one metabolic problem like overweight, high blood pressure, or diabetes.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
This trial tests a traditional Chinese herbal capsule (Linzhi Jianghuang Fufang) to treat non-alcoholic fatty liver disease—a buildup of fat in the liver not caused by alcohol. The study aims to see if this herbal treatment can safely reduce liver fat and improve metabolic health in people with early-stage fatty liver.
This study tests a Chinese herbal formula called Longqi Jiangzhi Decoction for people with non-alcoholic fatty liver disease (NAFLD) who also have a Traditional Chinese Medicine pattern of 'Spleen Deficiency with Damp-Heat'. If you qualify, you will receive the herbal decoction to see if it can reduce liver fat and improve your health.
This trial tests whether Fuzheng Huayu tablets can help people with fatty liver disease that has progressed to cirrhosis (scarring) that is still compensated (the liver is still working well). The goal is to see if the tablets slow or reverse liver damage.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.